HBVTECH
Biotech · Private
AAV vector-based gene therapy delivering anti-HBs antibody genes to achieve sustained hepatitis B virus suppression
- Grants
- $300K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A New HBV Drug For Establishing Durable Antiviral Efficacy of HBV Treatment | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2290 | Precision Fermentation, Inc. | — | $53M |
| 2291 | Xencor | — | $46M |
| 2292 | Perceive Biotherapeutics, Inc. | — | $40M |
| 2293 | HBVTECH | — | — |
| 2294 | Fortress Biotech, Inc. | — | $39M |
| 2295 | Tortugas Neuroscience | — | — |
| 2296 | FutureDerm Inc. | — | $468K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Eliminating Hepatitis B Virus Cccdna And Rcdna And The Hepatitis B Drugs Used In The Methods Thereofapplication
- Methods For Reducing Hepatitis B Virus Surface Antigen (hbsag) And The Hepatitis B Drugs Used In The Methods Thereofapplication
- Methods For Eliminating Hepatitis B Virus Cccdna And Rcdna And The Hepatitis B Drugs Used In The Methods Thereofapplication
- Methods For Eliminating Hepatitis B Virus Cccdna And Rcdna And The Hepatitis B Drugs Used In The Methods Thereofapplication
- Methods For Reducing Hepatitis B Virus Surface Antigen (hbsag) And The Hepatitis B Drugs Used In The Methods Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.